EUROFINS SCIENT Revenue 2018-2024 | ERFSF
- EUROFINS SCIENT revenue for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT revenue for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- EUROFINS SCIENT annual revenue for 2024 was $7.522B, a 6.68% increase from 2023.
- EUROFINS SCIENT annual revenue for 2023 was $7.051B, a 0.3% decline from 2022.
- EUROFINS SCIENT annual revenue for 2022 was $7.072B, a 11.02% decline from 2021.
EUROFINS SCIENT Annual Revenue (Millions of US $) |
|
---|---|
2024 | $7,522 |
2023 | $7,051 |
2022 | $7,072 |
2021 | $7,948 |
2020 | $6,213 |
2019 | $5,110 |
2018 | $4,466 |
2017 | $3,359 |
2016 | $2,762 |
2015 | $0 |
EUROFINS SCIENT Quarterly Revenue (Millions of US $) |
|
---|---|
2024-12-31 | |
2024-06-30 | |
2023-06-30 | |
2022-12-31 | |
2021-12-31 | |
2021-06-30 | |
2020-12-31 | |
2020-06-30 | |
2019-12-31 | |
2019-06-30 | |
2018-12-31 | |
2018-06-30 | |
2017-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $13.598B | $7.522B |
Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $138.024B | 25.89 |
CVS Health (CVS) | United States | $80.885B | 10.05 |
Elevance Health (ELV) | United States | $75.961B | 9.80 |
Cencora (COR) | United States | $57.110B | 19.87 |
DiDi Global (DIDIY) | China | $25.792B | 27.40 |
Labcorp Holdings (LH) | United States | $20.561B | 16.68 |
Natera (NTRA) | United States | $20.462B | 0.00 |
BioMerieux (BMXMF) | France | $16.861B | 0.00 |
CochLear (CHEOY) | Australia | $12.760B | 0.00 |
Solventum (SOLV) | United States | $12.748B | 13.49 |
ICON (ICLR) | Ireland | $11.757B | 10.93 |
Revvity (RVTY) | United States | $11.304B | 19.45 |
Viatris (VTRS) | United States | $10.481B | 3.60 |
Medpace Holdings (MEDP) | United States | $8.988B | 23.87 |
Sonic Healthcare (SKHHY) | Australia | $8.788B | 0.00 |
Avantor (AVTR) | United States | $8.736B | 12.69 |
HealthEquity (HQY) | United States | $8.317B | 36.43 |
Charles River Laboratories (CRL) | United States | $7.584B | 14.86 |
Caris Life Sciences,�Inc (CAI) | United States | $7.355B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.851B | 28.56 |
BrightSpring Health Services (BTSG) | United States | $3.527B | 32.35 |
Sotera Health (SHC) | United States | $3.230B | 18.35 |
Surgery Partners (SGRY) | United States | $2.799B | 36.40 |
Alignment Healthcare (ALHC) | United States | $2.623B | 0.00 |
Concentras Parent (CON) | United States | $2.543B | 14.70 |
Organon (OGN) | United States | $2.485B | 2.64 |
GeneDx Holdings (WGS) | United States | $2.331B | 89.77 |
Progyny (PGNY) | United States | $1.992B | 43.85 |
Ardent Health (ARDT) | United States | $1.991B | 8.49 |
PACS (PACS) | United States | $1.897B | 0.00 |
Premier (PINC) | United States | $1.719B | 13.05 |
GoodRx Holdings (GDRX) | United States | $1.697B | 33.93 |
Teladoc Health (TDOC) | United States | $1.388B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.285B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.100B | 8.37 |
CareDx (CDNA) | United States | $1.058B | 16.53 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
Agilon Health (AGL) | United States | $0.911B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.761B | 7.13 |
Nutex Health (NUTX) | United States | $0.632B | 9.57 |
InnovAge Holding (INNV) | United States | $0.564B | 0.00 |
Embecta (EMBC) | United States | $0.560B | 3.77 |
SBC Medicals (SBC) | United States | $0.511B | 0.00 |
LifeMD (LFMD) | United States | $0.497B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.473B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.472B | 10.63 |
Omada Health (OMDA) | $0.463B | 0.00 | |
So-Young (SY) | China | $0.455B | 0.00 |
Enhabit (EHAB) | United States | $0.354B | 29.17 |
COMPASS Pathways (CMPS) | United Kingdom | $0.333B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.309B | 0.00 |
Oncology Institute (TOI) | United States | $0.265B | 0.00 |
Beauty Health (SKIN) | United States | $0.207B | 0.00 |
DocGo (DCGO) | United States | $0.142B | 23.17 |
Pheton Holdings (PTHL) | China | $0.136B | 0.00 |
Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.072B | 0.00 |
KindlyMD (NAKA) | United States | $0.071B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.047B | 0.00 |
Biodesix (BDSX) | United States | $0.045B | 0.00 |
ModivCare (MODV) | United States | $0.045B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |